Tibet Aim Pharm (SZSE:002826) EBIT per Share : ¥0.30 (TTM As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm EBIT per Share?

Tibet Aim Pharm's EBIT per Share for the three months ended in Jun. 2024 was ¥0.07. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ¥0.30.

During the past 12 months, the average EBIT per Share Growth Rate of Tibet Aim Pharm was 27.80% per year. During the past 3 years, the average EBIT per Share Growth Rate was 4.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was 1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Tibet Aim Pharm's EBIT per Share or its related term are showing as below:

SZSE:002826' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -28.6 Med: -3.4 Max: 19.7
Current: 4.9

During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Tibet Aim Pharm was 19.70% per year. The lowest was -28.60% per year. And the median was -3.40% per year.

SZSE:002826's 3-Year EBIT Growth Rate is ranked worse than
54.48% of 848 companies
in the Drug Manufacturers industry
Industry Median: 7.25 vs SZSE:002826: 4.90

Tibet Aim Pharm's EBIT for the three months ended in Jun. 2024 was ¥13.8 Mil.

Tibet Aim Pharm EBIT per Share Historical Data

The historical data trend for Tibet Aim Pharm's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Aim Pharm EBIT per Share Chart

Tibet Aim Pharm Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

0.16

0.27

0.26

0.30

Tibet Aim Pharm Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EBIT per Share	Get a 7-Day Free Trial															0.04	0.08	-0.03	0.18	0.07

Tibet Aim Pharm EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Tibet Aim Pharm's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	57.513	/	191.893
=	0.30

Tibet Aim Pharm's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	13.847	/	191.589
=	0.07

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.30

Tibet Aim Pharm (SZSE:002826) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Tibet Aim Pharm EBIT per Share Related Terms

Thank you for viewing the detailed overview of Tibet Aim Pharm's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Tibet Aim Pharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000

Website

http://www.emyy.cn

Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.

Executives

Peng Hui	Director
Pang Guo Qiang	Directors, executives
Li Qian Jin	Securities Affairs Representative
Liu Hang	Supervisors

Tibet Aim Pharm Headlines

No Headlines